Department of Pediatrics, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ.
Department of Pediatrics, Columbia University Irving Medical Center, New York, NY.
Pediatr Crit Care Med. 2019 Aug;20(8):e380-e385. doi: 10.1097/PCC.0000000000002014.
Ventilator-associated infections are a major contributor to antibiotic use in the PICU. Quantitative or semiquantitative assessment of neutrophils (microscopic purulence) is routinely reported in positive cultures from tracheal aspirates. The role of microscopic purulence in guiding antibiotic therapy or its association with symptoms of ventilator-associated infections is less described in children. We examine microscopic purulence as an independent predictor of antibiotic use for positive tracheal aspirate cultures in the PICU.
Retrospective cohort study.
Tertiary care pediatric hospital.
Children admitted to the PICU, neuro-PICU, or cardiac PICU with a positive tracheal aspirate culture from January 1, 2016, to December 31, 2016.
None.
Positive tracheal aspirate cultures were reviewed. The outcome variable was antibiotic treatment that targeted the positive tracheal aspirate culture. The predictor variable was microscopic purulence, defined as moderate or many neutrophils on Gram stain report. Competing predictors included demographics, comorbidities, vital signs changes, respiratory support, and laboratory values. Of 361 positive cultures in the cohort, 81 (22%) were treated with antibiotics. Positive cultures with microscopic purulence were targeted for therapy more frequently (30% vs 11%). Microscopic purulence was the strongest predictor for antibiotic therapy (odds ratio, 3.3; 95% CI, 1.6-6.8) compared with fever (odds ratio, 2.0; 95% CI, 1.0-4.1) or increased respiratory support (odds ratio, 2.3; 95% CI, 1.2-4.3). There was no significant variation in symptomatology between microscopic purulence reported as moderate or many versus other (e.g., fever -24% vs 22%, increased respiratory support -36% vs 28%). Microscopic purulence was less prevalent with longer ventilator durations at the time of sampling.
Microscopic purulence was an independent predictor of antibiotic therapy for positive tracheal aspirate cultures in our PICUs. However, microscopic purulence was not associated with clinical symptomatology.
呼吸机相关性感染是小儿重症监护病房(PICU)抗生素使用的主要原因。气管吸出物的阳性培养物通常报告中性粒细胞(显微镜下脓性)的定量或半定量评估。在儿童中,显微镜下脓性在指导抗生素治疗中的作用或与呼吸机相关性感染症状的关系描述较少。我们研究了显微镜下脓性作为指导 PICU 中阳性气管吸出物培养物使用抗生素的独立预测因子。
回顾性队列研究。
三级儿科医院。
2016 年 1 月 1 日至 12 月 31 日期间入住 PICU、神经 PICU 或心脏 PICU 且气管吸出物阳性培养物的儿童。
无。
对阳性气管吸出物培养物进行了回顾。因变量为针对阳性气管吸出物培养物的抗生素治疗。预测因子为革兰氏染色报告中度或大量中性粒细胞的显微镜下脓性。竞争预测因子包括人口统计学、合并症、生命体征变化、呼吸支持和实验室值。在队列中的 361 个阳性培养物中,有 81 个(22%)接受了抗生素治疗。显微镜下脓性的阳性培养物更常被用于治疗(30%比 11%)。与发热(比值比,2.0;95%置信区间,1.0-4.1)或呼吸支持增加(比值比,2.3;95%置信区间,1.2-4.3)相比,显微镜下脓性是抗生素治疗的最强预测因子(比值比,3.3;95%置信区间,1.6-6.8)。在报告为中度或大量的显微镜下脓性与其他(例如发热 -24%比 22%,呼吸支持增加 -36%比 28%)之间,症状学没有明显差异。随着采样时呼吸机使用时间的延长,显微镜下脓性的患病率降低。
在我们的 PICU 中,显微镜下脓性是阳性气管吸出物培养物使用抗生素的独立预测因子。然而,显微镜下脓性与临床症状无关。